Comparative analysis of six European influenza vaccines

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 2, 1996, Pages 121-127

  Chaloupka, I ^a   Schuler, A ^a   Marschall, M ^a   Meier Ewert, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; MATRIX PROTEIN; OVALBUMIN; SIALIDASE; VIRUS NUCLEOPROTEIN;

ARTICLE; DRUG HYPERSENSITIVITY; ENZYME ACTIVITY; FOOD ALLERGY; HEMAGGLUTINATION TEST; IMMUNOBLOTTING; INFLUENZA VACCINATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT;

ANTIGENS, VIRAL; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; HEMAGGLUTINATION TESTS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; VIRAL PROTEINS;

EID: 0029872702     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01591484     Document Type: Article

References (14)

1. Aymard M, Cox NJ, Dubois G, Ghendon Y, Hannoun C, Hampson A, Haaheim LR, Morgan-Capner P, Saliou P, Tamblyn S: Recommendations of the 7th European Meeting of Influenza and Its Prevention. European Journal of Epidemiology 1994, 10: 525-526.
2. Wiselka M: Influenza: diagnosis, management and prophylaxis. British Medical Journal 1994, 308: 1341-1345.
3. Weeke-Lüttmann M: Licensing and control authority batch release of influenza vaccine in Germany in accordance with EEC regulations. European Journal of Epidemiology 1994, 10: 513-515.
4. Recommendations of the composition of influenza virus vaccines for the 1994-95 season. World Health Organization Bulletin 1994, 72: 516.
5. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72: 248.
6. Palmer DF, Coleman MT, Dowdle WR, Schild GC: Advanced laboratory techniques for influenza diagnosis. U.S. Department of Health, Education and Welfare. Immunology Series 1975, 6: 34-36.
7. Lambre CR, Terzedis H, Greffard A, Webster RG: Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. Journal of Immunological Methods 1990, 135: 49-57.
8. Vaccinum influenzae inactivatum ex virorum fragmentis praeparatum. European Pharmacopoeia Special Print 1994: 1-4.
9. Vaccinum influenzae inactivatum ex corticis antigeniis praeparatum. European Pharmacopoeia Special Print 1994: 1-3.
10. Statement on influenza vaccination for the 1994-95 season. Canadian Medical Association Journal 1994, 151: 593-597.
11. Renfrey S, Watts A: Morphological and biochemical characterisation of influenza vaccines commercially available in the United Kingdom. Vaccine 1994, 12: 747-752.
12. Yankauckas MA, Morrow JE, Parker SE, Abai A, Rhodes GH, Dwarki VJ, Gromkowski SH: Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biology 1993, 12: 771-776.
13. Gorse JG, Campbell MJ, Otto EE, Powers DC, Chambers GW, Newman FK: Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. Journal of Infectious Diseases 1995, 172: 1-10.
14. Justewicz DM, Doherty PC, Webster RG: The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin. Journal of Virology 1995, 69: 5414-5421.